Biocon: Price Erosion Impacts Growth in Biosimilars
Biocon reported weak numbers from the last 3 quarters, as the industry is facing price erosion challenges. Furthermore, the company is trading at...
133 Views
Biocon: Covid Related Challenges Drag Q1
Biocon is a leading biopharma company operating in biologics, small molecules, branded formulations and contract research.
97 Views
Biocon Limited: Is It Sign Of Window Dressing?
Classification of Bicara from subsidiary to associate can be a logical step but re-classification before stake sale raises question on the...
723 Views
Forensic Accounting | High Risk Companies in India
As promised at Smartkarma Webinar | Accounting and Insider Diagnostics, we have extended our forensic analysis model to India. To learn more about...
511 Views
Biocon: Covid-19 Respite Uncertain
Shares of Biocon Ltd (BIOS IN) escalated almost by 5.5% on Tuesday, 14th July after the Drugs Controller General of India (DCGI) approved to market...
333 Views